1262 — Labixiaoxin Snacks Income Statement
0.000.00%
Last trade - 00:00
- HK$215.29m
- HK$605.50m
- CNY764.38m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 467 | 509 | 648 | 684 | 764 |
Cost of Revenue | |||||
Gross Profit | 139 | 167 | 224 | 244 | 219 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 577 | 453 | 601 | 725 | 846 |
Operating Profit | -110 | 55.5 | 47.5 | -40.3 | -82.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -153 | 16 | 17 | -67.7 | -105 |
Provision for Income Taxes | |||||
Net Income After Taxes | -170 | -29.4 | -65.2 | -75.3 | -105 |
Net Income Before Extraordinary Items | |||||
Net Income | -170 | -29.4 | -65.2 | -75.3 | -105 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -170 | -29.4 | -65.2 | -75.3 | -105 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.095 | -0.06 | -0.056 | -0.047 | -0.066 |